HOME >> MEDICINE >> NEWS
Lupus Foundation Of America Awards Summer Internship To Student Working At Wistar Institute

PHILADELPHIA, Penn. -- Su-jean Seo, a native of Corbin, Kentucky, has been awarded the Lupus Foundation of America's Gina Finzi Memorial Student Summer Fellowship for a research project she is conducting at The Wistar Institute.

The fellowship was designed to encourage young scientists to participate in lupus related research under the supervision of an established scientific investigator. It will support Ms. Seo's work in Dr. Jan Erikson's laboratory in Wistar's Tumor Immunology Program.

Ms. Seo graduated cum laude from Yale University with a B.S. degree in molecular biophysics and biochemistry. During her junior and senior years, she worked as a research assistant in the Section of Neurobiology at Yale University's School of Medicine. Her specific project was on the "generation of a monoclonal antibody against a breast adenocarcinoma specific antigen."

Ms. Seo is currently enrolled in a joint Ph.D./M.D. degree program at the University of Pennsylvania. She is doing her graduate rotation at Wistar, where her research focuses on antigens targeted in autoimmune diseases such as lupus erythematosus.

Following her graduation, Ms. Seo hopes to combine clinical practice with research in immunology.

The Wistar Institute, established in 1892, was the first independent medical research facility in the country. For more than 100 years, Wistar scientists have been making history and improving world health through their development of vaccines for diseases that include rabies, German measles, infantile gastroenteritis (rotavirus), and cytomegalovirus; discovery of molecules like interleukin-12, which are helping the immune system fight bacteria, parasites, viruses and cancer; and location of genes that contribute to the development of diseases like breast, lung and prostate cancer. Wistar is a National Cancer Institute Cancer Center.


'"/>

Contact: Diana Cutshall
dcutshall@wista.wistar.upenn.edu
(215) 898-3716
The Wistar Institute
7-Jul-1998


Page: 1

Related medicine news :

1. Lupus discovery may pave way to better-designed COX-2 inhibitors
2. Lupus Today: Research into Action
3. Hopkins Researchers Develop New Therapy For Autoimmune Disorders Such As Rheumatoid Arthritis And Lupus
4. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
5. Top honor for head of Epilepsy Foundation
6. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
7. Prentiss Foundation awards $5 million to University Hospitals
8. Endocrine Society and Hormone Foundation call for increased research
9. Foundation to honor physicians and community health initiatives around the world
10. Donald W. Reynolds Foundation awards UT Southwestern $12 million to continue Dallas Heart Study
11. NYU Child Study Center and The Bear Stearns Charitable Foundation launch outreach campaign

Post Your Comments:
(Date:4/18/2014)... (April 21, 2014) -- A group of scientists ... and the Sanders-Brown Center on Aging has found ... and neuropsychological function in Parkinson,s disease (PD). ... , the study, which assessed cognitive function in ... the dopamine replacement therapy commonly used to treat ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
Cached News: